Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Arthritis Rheumatol. 2022 Jan 4;74(2):263–273. doi: 10.1002/art.41930

Table 3.

Categorization of renal and extra-renal disease courses between two consecutive assessments (Visit-1 and Visit-2) as used in the Standardized Steroid dosing Regimen (SSR)

Renal courses Extra-renal course$
Induction therapy (weeks 1–26) Maintenance therapy (after week 27)
LN* - Active worse#: LN flare after PRR or CRR: Active - Much worse:
Worsening of ≥ 1 LN-RV† Worsening (persistent¥ & substantial) of ≥1 LN-RV Δ SLEDAI score: ≥ +8
LN - Active stable: LN worse# after PRR or CRR: Active - Mild-moderate worse
Neither Active Worse nor Active Improved Worsening of ≥ 1 LN-RV Δ SLEDAI score: +4 to +7
LN - Active improved: PRR stable: Active - stable:
Improvement of ≥1 LN-RV with the remaining LN-RV(s) not being worse PRR with changes of LN-RVs not qualifying for being worse or improved Δ SLEDAI score: ± 3
PRR‡: PRR improved: Active - Improved:
Clinically relevant improvement of ≥2 LN-RVs with the remaining LN-RV not being worse PPR with improvement of ≥ 1 LN-RV with the remaining LN-RV(s) not being worse Δ SLEDAI score: ≤- 4
LN - Inactive: CRR: Inactive:
All LN-RVs are within normal range All LN-RVs are within normal range Absolute SLEDAI score: ≤ 2
*

Lupus Nephritis

#

All “worsening” is considered to be due to LN

†

Lupus nephritis response variables, i.e., Urine protein creatinine ratio (UPCR), hematuria, estimated glomerular filtration rate (eGFR). Normal values for the LN-RVs are always considered as “improved” for the purpose of the course definitions (for details please see Figure 2)

‡

Partial renal remission assesses the change between baseline and week 26 and can only be measured starting week 26 of induction therapy

Complete renal remission

¥

Worsening of 1 or more LN-RVs on >2 subsequent time points >1 week(s) apart as follows: Newly abnormal eGFR or abnormal eGFR that decreased by >10%; Persistent increase of UPCR to >0.5, after CRR; Persistent doubling of UPCR with values >1.0, after PRR; Newly active or worsening by 2 categories of urine RBCs.

$

Based on changes in the score of the SLE disease activity index, version 2K. For item definitions please see: Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91.